Trials / Completed
CompletedNCT01342445
Effects of LDX on Functioning of College Students With ADHD
Effects of Vyvanse on the Behavioral, Academic, and Psychosocial Functioning of College Students With ADHD
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 50 (actual)
- Sponsor
- University of Rhode Island · Academic / Other
- Sex
- All
- Age
- 18 Years – 28 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study was to evaluate the effects of lisdexamfetamine dimesylate, a prodrug stimulant, on the behavioral, academic, and psychosocial functioning of college students with attention-deficit/hyperactivity disorder (ADHD). Twenty-five college students with ADHD from two universities (University of Rhode Island and Lehigh University) completed a within-subject, placebo-controlled research trial. Dependent measures tapping behavioral, psychosocial, and academic functioning were completed on a weekly basis across five conditions (baseline, placebo, and 30-mg, 50-mg, and 70-mg lisdexamfetamine).
Detailed description
Objective: Evaluate stimulant medication on symptoms and functioning for college students with ADHD using double-blind, placebo-controlled, crossover design. Method: Participants included 24 college students with ADHD and 26 college students without psychopathology. Lisdexamfetamine dimesylate (LDX) examined for ADHD participants over five weekly phases (no-drug baseline, placebo, 30, 50, \& 70-mg LDX per day). Self-report rating scales of functioning and direct assessment of ADHD symptoms, verbal learning/memory, and adverse side-effects were collected (baseline only for control students).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | lisdexamfetamine dimesylate | 30-mg, 50-mg, 70-mg administered for one week in context of double-blind, placebo-controlled crossover design |
| DRUG | Placebo |
Timeline
- Start date
- 2009-09-01
- Primary completion
- 2010-12-01
- Completion
- 2010-12-01
- First posted
- 2011-04-27
- Last updated
- 2025-04-24
- Results posted
- 2014-04-08
Locations
2 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT01342445. Inclusion in this directory is not an endorsement.